BioSpace News Archive

Valens GroWorks Corp. today announced that it has signed a letter of intent with Colombian-based licensed producer Eticann S.A.S. Zomac (“Eticann”) for:

ACER’S NEW WINDOWS MIXED REALITY HEADSET IS OPTIMIZED FOR VIRZOOM’S REVOLUTIONARY VZFIT VR FITNESS SYSTEM

Luye Pharma Group released its financial results for the first half of 2018 on August 26, with the financial report showing the company has maintained strong business performance and double-digit growth in the sale of its established products - significantly higher than the industry average.

Soligenix, Inc. announced today that Dr. Oreola Donini, Chief Scientific Officer, will be presenting preclinical and clinical data illustrating the potential utility of the Innate Defense Regulator technology in the treatment of infectious disease in a poster session at the upcoming European Society of Clinical Microbiology and Infectious Diseases / American Society of Microbiology Conference

Concord Medical Services Holdings Limited today announced its unaudited consolidated financial results for the six months ended June 30, 2018[1].

TapImmune Inc. will participate at two upcoming industry conferences.

Presentation to Highlight the Challenges of Viral Targets in Cancer